Gracell Biotechnologies's activity chart (see below) currently has 24 price targets and 24 ratings on display.
Analysts' price targets on this stock were met 33.33% of the time, taking 76.33 days on average.
Most recent stock forecast was given by JOSEPH CATANZARO from MIZUHO on 27-Dec-2023. First documented stock forecast 30-Apr-2021.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 30-Apr-2021
$10
$10
2 years 10 months 26 days ago
(27-Dec-2023)
3/6 (50%)
$0.08 (0.81%)
261
Buy Since 27-Mar-2023
$10
$7
2 years 10 months 26 days ago
(27-Dec-2023)
3/3 (100%)
$0.08 (0.81%)
102
Buy Since 08-Dec-2022
$10
$13
2 years 10 months 27 days ago
(26-Dec-2023)
2/4 (50%)
$0.08 (0.81%)
95
Buy Since 04-Apr-2022
$20
2 years 10 months 27 days ago
(26-Dec-2023)
0/2 (0%)
$13.93 (229.49%)
Buy Since 19-Oct-2023
$11
3 years 1 months 3 days ago
(19-Oct-2023)
0/2 (0%)
$8.4 (323.08%)
What is GRCL (Gracell Biotechnologies) average time for price targets to be met?
Which analyst most recently updated their price target on GRCL (Gracell Biotechnologies)?
Which analyst has the lowest performance score on GRCL (Gracell Biotechnologies) with a proven track record?
Which analyst has the most public recommendations on GRCL (Gracell Biotechnologies)?
Which analyst is the currently most bullish on GRCL (Gracell Biotechnologies)?
Which analyst is the currently most reserved on GRCL (Gracell Biotechnologies)?